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The  purpose  of  this  study  was  to evaluate  the  feasibility  of a novel  dissection  technique  of surgical
specimens  in different  cases  of  pancreatic  tumors  and  provide  a  radiologic  pathologic  correlation.  In
our hospital,  that  is  a referral  center  for pancreatic  diseases,  the  macroscopic  evaluation  of  the  pan-
createctomy  specimens  is performed  by  the  pathologists  using  the  axial  slicing  technique  (instead  of
the traditional  procedure  with  longitudinal  opening  of the  main  pancreatic  and/or  common  bile  duct
and slicing  along  the plane  deﬁned  by both  ducts).  The  specimen  is sliced  in  an  axial  plane  that  is
perpendicular  to  the  longitudinal  axis  of  the  descending  duodenum.  The  procedure  results  in a  large
number  of thin slices  (3–4 mm).  This  plane  is  identical  to that  of  CT or MRI  and  correlation  between
pathology  and  imaging  is  straightforward.  We  studied  70 cases  of  suspected  different  solid  and  cystic
pancreatic  tumors  and  we  correlated  the  tumor  size  and  location,  the  structure—consistency  (areas  of
necrosis—hemorrhage—ﬁbrosis—inﬂammation),  the  degree  of vessels’  inﬁltration,  the  size  of pancreatic
and  common  bile  duct  and  the  distance  from  resection  margins.  Missed  ﬁndings  by imaging  or  pitfalls
were  recorded  and  we  tried to explain  all  discrepancies  between  radiology  evaluation  and  the  histopatho-
logical  ﬁndings.  Radiologic-pathologic  correlation  is  extremely  important,  adding  crucial  information  on
imaging  limitations  and  enabling  quality  assessment  of  surgical  specimens.  The  deep  knowledge  of  dif-
ferent  pancreatic  tumors’  consistency  and  way  of  extension  helps  to improve  radiologists’  diagnostic
accuracy  and  minimize  the  radiological-surgical  mismatching,  preventing  patients  from  unnecessary
surgery.
© 2016  Published  by Elsevier  Ltd.  This  is an  open  access  article  under the  CC  BY-NC-ND  license. Introduction
Pancreatic tumors represent a heterogeneous group of diseases
resenting with different imaging characteristics. Malignant poten-
ial cannot always be decided on the basis of imaging ﬁndings and
espite the advantages of multidetector computed tomography
MDCT) and magnetic resonance imaging (MRI), there is a well-
nown underestimation of pancreatic adenocarcinoma extent as
ell as a grey zone concerning mainly the treatment decision on
ystic lesions.
In any case, imaging reﬂects the tumor characteristics on
istopathology. Radiologic-pathologic correlation is a well estab-
∗ Corresponding author at: Konstantopouleio General Hospital, Radiology Depart-
ent, 3-5 Agias Olgas street, 14233 N. Ionia, Athens, Greece. Fax: +30 2132057224.
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ttp://dx.doi.org/10.1016/j.ejro.2016.02.001
352-0477/© 2016 Published by Elsevier Ltd. This is an open access article under the CC B(http://creativecommons.org/licenses/by-nc-nd/4.0/).
lished way to understand and explain the imaging ﬁndings and
realize the potential preoperative limitations. In our center, which
is dedicated to hepatico-biliary and pancreatic surgery, we  have
recently adopted the axial slicing technique in pancreatic speci-
mens. This technique permits the accurate correlation with axial
MDCT and/or MRI  images.
This is the ﬁrst study to be performed on this novel technique
of pancreatectomy specimen slicing, and there are not similar
studies in the literature. The axial slicing technique offers many
advantages in accurate estimation of tumors extend and in eval-
uation of possible discrepancies between the radiological and the
histopathological ﬁndings. It can be applied as an important learn-
ing tool for the radiologists increasing their diagnostic capabilities
in difﬁcult or atypical cases of pancreatic tumors.
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Circumferential resection margins in a pancreatoduodenectomy specimen:0 C. Triantopoulou et al. / European Jo
. Materials-methods
.1. Patients group
This study is based on 70 cases of suspected pancreatic
eoplasms evaluated by multi-detector computed tomography
MDCT) and/or Magnetic Resonance Imaging (MRI) who  underwent
urgery in our hospital. The patients’ age ranged between 37 and
1 years old, 39 men  and 31 women.
67 patients were considered as resectable while in three cases
hey met  the criteria of borderline resectable disease and under-
ent surgery following chemotherapy as decided during the
ultidisciplinary Team meeting. For resectability evaluation, the
ecent NCCN guidelines [1] as well as the consensus statement of
he International Study Group of Pancreatic Surgery [2] were used.
.2. Imaging evaluation
MDCT or MRI  using a dedicated pancreatic protocol and state
f the art techniques [3] was performed, no more than two  weeks
efore surgery. The triple contrast phases taken on MDCT included
 nonenhanced phase, a late arterial phase (10-s delay from the
ime of peak aortic enhancement), and a portal venous phase (35-s
elay). Contrast-enhanced phases were performed craniocaudally,
ith thin collimation (0.5 or 0.625 mm),  120 kVp, and automatic
odulation of the milliamperes. Three-millimeter axial images and
 × 5-mm coronal and sagittal reformatted images were sent to the
icture archiving and communication system and 0.5-mm-thick
ections were sent to workstations for post processing (multiplanar
eformations, maximum intensity projections, volume rendering
nd curved planar reformations) [4].
For the evaluation of resectability in locally advanced lesions
ulti detector CT angiography was applied (MDCTA) using an
dditional early arterial phase. We  routinely use bolus tracking
ith automatic power injectors and we set a region of interest
n the abdominal aorta at the level of the celiac axis with a pre-
eﬁned enhancement threshold at 150HU. The maximum degree
f circumferential contact (CC), the length of contact (LC) of the
umor with major vessels and the luminal narrowing of vessels
venous deformity, [VD]) were evaluated. For the reporting we used
he standardized adenocarcinoma radiology reporting template as
ublished in the consensus statement of the Society of Abdominal
adiology and the American Pancreatic Association [5].
The sequences applied on MRI/MRCP were: T1-weighted
radient-echo; T2-weighted axial and coronal sequences, usually
urbo spin echo; two dimensional (2D) and three dimensional (3D)
RCP; and T1-weighted 3D gradient-echo (GRE) before and after
ntravenous administration of gadolinium. Detection of pancreatic
denocarcinoma on MRI  was based on unenhanced T1W (fat-
uppressed) images and pancreatic-phase postgadolinium T1W
poiled GRE. Adenocarcinomas were expected to present as hypo-
ascular lesions, while neuroendocrine tumors were expected to
ppear as hypervascular lesions. Magnetic Resonance Cholagiopan-
reatography (MRCP) was always done for tumors located in the
ancreatic head and for periampullary lesions.
In equivocal cases Endoscopic Ultrasound (EUS) was  performed
nd ﬁnal decision for surgery was taken after the evaluation of EUS-
NA results.
.3. Surgical techniques
All cases were reviewed preoperatively in our Multidisciplinary
eam meeting, where the optimal treatment strategy for each
atient is decided. Staging laparoscopy in assessing pancreatic can-
er resectability is not routinely used [6]. Pancreatectomies were
erformed using a standard technique whereas in the majorityanterior surface (red) (a), facing the SMV (green) (a), facing the SMA  (yellow) (a,b)
and  posterior surface(blue) (b). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
of cases pylorus was  preserved (pylorus-preserving pancreatico-
duodenectomy: PPPD). Total pancreatectomy was carried out in
cases of intraoperative repeated frozen section positive margins
and in cases of multifocal intraductal papillary mucinous neoplasm
(IPMN). Moreover total pancreatectomy was performed in patients
where the pancreatic anastomosis could not be carried out with
safety, mainly in those with soft and friable pancreatic texture.
Nowadays, despite the fact that clear and widely accepted def-
initions of resectability and borderline resectability exist, it seems
that surgeons’ capabilities can deﬁne resectability in many cases.
The presence of distant metastases along with extensive, cir-
cumferential encasement of superior mesenteric artery or celiac
abutment is considered as a non-resectable disease. Occurrences
of inferior vena cava or aortic invasion and presence of unre-
constructible portomesenteric occlusion are also included in the
deﬁnition of unresectable disease [7].
However, as mentioned above, surgeons’ capabilities and expe-
rience, especially in high volume centers, have lead to pancreatic
surgery toward a new era regarding vascular reconstructions.
There is clear evidence supporting straightforward exploration and
resection in cases of reconstructible involvement of the mesenteri-
coportal axis where complete tumor excision (R0) can be achieved
[7–9]. On the other hand, arterial reconstruction cannot be regarded
as a “gold standard”. Although there are reports in favor of SMA  or
celiac axis resection and reconstruction, there is lack of level I evi-
dence regarding the beneﬁts of arterial resection [7,8,10]. Another
critical issue, often debated, is the extend of lymphadenectomy. We
routinely perform standard lymphadenectomy as proposed by the
ISGPS group [8,11].
2.4. Histopathology evaluationIn our hospital, the macroscopic evaluation of the PPPD spec-
imens is performed by the pathologists using the axial slicing
technique. After ﬁxation and prior to slicing, inking of the margins
and specimen surfaces is performed (Fig. 1a and b). Different col-
C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59 51
Fig. 2. After axial slicing of a pancreatoduodenectomy specimen, the slices are arranged in sequential order. To allow optimal correlation with preoperative imaging, they
are  arranged from cranial to caudal.
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rs of ink are used, according to an agreed color code. This allows
nequivocal identiﬁcation of the surfaces during both macroscopic
nd microscopic examination.
The specimen is sliced in an axial plane that is perpendicular to
he longitudinal axis of the descending duodenum and it results in a
arge number of thin slices (3–4 mm),  12 on average or more (Fig. 2).
his allows good view of all the key anatomical structures such as
he ampulla, common bile duct and main pancreatic duct which
re always found at the same position in the specimen slices and
re therefore easily identiﬁed. Given this, any pathological lesion is
dentiﬁed easily and is located in relationship with the surround-
ng anatomical structures. As far as the assessment of the margin
tatus is concerned, with this slicing technique, the entire surface
f the pancreatic head can be inspected in detail in every specimen the pancreatic head on contrast enhanced CT (yellow arrow). Cystic part of a solid
ure legend, the reader is referred to the web version of this article.)
slice. Taking in consideration all the above, this technique facilitates
tissue sampling for microscopic examination.
This plane is identical to that of CT imaging or MRI leading to
a straightforward radiological-pathological correlation. For tumors
located in the body and tail we use the sagittal imaging plane for
accurate correlation.
3. Results
The ﬁnal results of the total 70 cases after histopathology evalu-
ation were as follows: 33 pancreatic ductal adenocarcinomas and 2
acinar cell carcinomas, 4 ampullary adenocarcinomas, 6 neuroen-
docrine tumos (NETs), 4 common bile duct adenocarcinomas, 1
duodenal adenocarcinoma, 1 gastrointestinal stromal tumor (GIST),
52 C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59
Fig. 4. Radiologic-pathologic correlation of an isoattenuating pancreatic adenocarcinoma on contrast enhanced CT due to ﬁbrosis. Dilated pancreatic duct (blue arrow) and
common bile duct (yellow arrow) are also evident. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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 ampullary adenoma, 2 microcystic and 1 macrocystic serous ade-
omas, 4 mucinous cystic neoplasms (MCN), 5 intraductal papillary
ucinous tumors (IPMN), 2 solid pseudopapillary tumors (SPT), 1
aragaglioma, 1 sclerosing cholangitis, 1 focal autoimmune pan-
reatitis, 1 ampulla ﬁbrosis. Additionally four very small NETs and
ix IPMNs were incidentally revealed in 10 patients together with
he primary tumor.
.1. Typical ﬁndings in pancreatic adenocarcinoma
In 26 cases the imaging ﬁndings were typical and correlated
erfectly with the histopathologic ﬁndings. As typical ﬁndings were
onsidered: the presence of a mass showing attenuation difference, hypovascular lesion (Fig. 3), pancreatic ductal dilatation and cut
ff, double duct sign, atrophy of the gland upstream of the tumor,
igns of locally advanced disease, evidence of metastases or any
ombination of the above.duodenal GIST adjacent to the pancreatic head that was intact and displaced.
3.2. Atypical ﬁndings in pancreatic adenocarcinoma
As atypical-rare imaging ﬁndings were considered: the presence
of an isoattenuating mass (3 cases) (Fig. 4), an exophytic tumor
(ﬁnally proved to be a duodenal GIST) (Fig. 5), a diffusively inﬁl-
trating tumor (1 case) and the totally or partially cystic appearance
(2 cases) (Fig. 6). Isoattenuation was in all cases attributed to the
high grade of tumor ﬁbrosis. Concerning the cystic parts of the solid
tumors these were characterized by histopathology as cystic degen-
eration due to tumor necrosis, as cystic parts in variants of ductal
adenocarcinoma or as small retention cysts (Fig. 3).
3.3. The heterogenous group of cystic lesionsDespite the well known imaging difﬁculties in preoperative
differential diagnosis of the exact type of a cystic tumor, the
radiologic-pathologic correlation was  excellent in all cases of
C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59 53
Fig. 6. Tiny cystic areas inside a ductal adenocarcinoma are recognized and correlated on CT images and histopathology (blue arrows). (For interpretation of the references
to  color in this ﬁgure legend, the reader is referred to the web  version of this article.)
Fig. 7. Microcystic serous adenoma: typical sponge-like appearance of a large microcystic lesion perfectly correlated on T2-w MR  image and macroscopic evaluation.
Fig. 8. Macrocystic serous adenoma: the large cystic spaces and the thin septa are evident in this well-deﬁned benign cystic lesion on contract enhanced CT and macroscopy.
54 C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59
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rig. 9. A mucinous cystic neoplasm is shown, presenting a ﬁbrotic area (blue arrow
b:  H/EX200) an associated invasive carcinoma of less than 0.5 cm in size behind th
n  this ﬁgure legend, the reader is referred to the web  version of this article.)
icrocystic (Fig. 7) and macrocystic serous adenomas (Fig. 8), muci-
ous cystic neoplasms (MCN), different types of IPMNs and SPTs.
he solid and cystic parts were well correlated as well as the thick-
ess of the cyst wall and the component. In one case of mucinous
ystic neoplasm, microscopic evaluation revealed an associated
nvasive carcinoma, which was missed both on macroscopic eval-
ation and on imaging, even retrospectively (Fig. 9a and b).
.4. The hypervascular lesionsAll lesions that were proven to be NETs were hypervascular on
maging (Fig. 10). Although early arterial phase is not routinely
sed except for MDCTA, missed NETs are in most of the cases
elated to the very small size and not the contrast phase. The rare
Fig. 10. MRI-pathologic correlation of a small hypervasculno evidence of adenocarcinoma (a) in the macroscopic evaluation. Microscopically
tic area was  revealed (yellow arrow). (For interpretation of the references to color
paragaglioma was also hypervascular thus preoperative differen-
tial diagnosis from a NET was not achieved. Macroscopically, these
tumors share similar features (they are well-circumscribed mostly
solid tumors with pale or red-tan color) and even in microscopy
the differential diagnosis can be challenging (Fig. 11). Acinar cell
tumors were also hypervascular both on imaging and histopathol-
ogy.
3.5. The very small tumorsIn one case of ampullary tumor only secondary imaging ﬁndings
were evident (dilatation of pancreatic duct, common bile duct or
both) while the tumor was  not revealed because of its very small
size. Macroscopically, dilatation of both pancreatic and common
ar neuroendocrine tumor in the periampullary area.
C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59 55
Fig. 11. A rare pancreatic head hypervasccular paragaglioma showing marked heterogeneity was  revealed in a patient suffering from Hirschsprung’s disease.
Fig. 12. Nice depiction and correlation of the duodenum (blue arrow), the markedly dilated CBD (red arrow) and the less dilated MPD  (yellow arrow) (a). A very small
ampullary adenocarcinoma was  found that was  missed by imaging (red arrow in b). (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to  the web version of this article.)
56 C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59
Fig. 13. The ﬁbrotic and hyperplastic ampulla was misinterpreted as a tumor on imaging (blue arrow in a). A small duodenal NETG1, just above the ﬁbrotic ampulla, was
revealed on histopathology (blue arrow in b). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 14. A large periampullary tumor (blue arrow) together with an intraductal papillary mucinous neoplasm (IPMN) in the uncinate process (yellow arrow) is evident. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of this article.)
C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59 57
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aFig. 15. A misleading case of post inﬂammatory ﬁbrosis pres
ile duct was observed, caused by a small whitish tumor at the
mpulla (Fig. 12a and b). It should be noted that in one case it was
ossible to locate retrospectively a very small NET in the duodenal
all just above a ﬁbrotic ampulla of Vater, on arterial phase and
hin section axial MDCT. Macroscopically, it was a small tanned
olid tumor, 0.6 cm in greatest the diameter, located in the duodenal
all (Fig. 13a and b).
.6. The missed co-existed tumors
As mentioned before, in 10 patients histopathology revealed
ore than one lesion (4 NETs and 6 branch duct IPMNs). Two small
PMNs were located in retrospective evaluation of the images on
he workstation after the histopathology assessment. They were
ranch-duct IPMNs that macroscopically appeared as grapelike
ilations of the branch ducts (Fig. 14). The additional ﬁndings were
onsidered as incidental rather benign lesions and their presence
id not change the therapeutic plan.
.7. Imaging pitfalls
We  encountered three cases of wrong interpretation of a mass-
ike lesion as a tumor. The ﬁrst case presented with atypical imaging
nding of segmental autoimmune pancreatitis. In the second case
here was a “malignant” type stenosis of the distal common bile
uct in a patient with painless obstructive jaundice that was
nally proved to be ﬁbrosis (probably a chronic stage of sclerosing
holangitis) (Fig. 15). Macroscopic evaluation was also misleading,
evealing thickening of the common bile duct wall was  observed,
aising suspicion of carcinoma. Finally in the third case present-
ng with a double duct sign and an enlarged ampulla, evident also
n macroscopy, microscopic evaluation revealed hyperplasia and
brosis of the ampulla and an incidental ﬁnding of a small NET just
bove the ampulla (evident also in the retrospective review of thin
lices on MDCT images) (Fig. 13).
.8. The accuracy in resectability evaluation
67 patients were considered as resectable and 3 as borderline
esectable and were operated after preoperative chemotherapy
ccording to current guidelines. No surgery was aborted due to
etastases or locally advanced tumors, but ﬁnally there were three
1 resections (distance of the tumor from the resection margin less
han 1 mm).  Vascular reconstructions were performed in ﬁve cases
fter careful preoperative evaluation of MDCTA. Vascular anatomic as markedly thickened wall of the distal common bile duct.
variations were also noticed in ten cases (common hepatic artery
originating from the superior mesenteric artery, replaced or acces-
sory left or right hepatic artery, right hepatic artery originating from
the aorta and left hepatic artery originating from the common hep-
atic artery) and were also studied properly on 3D images before
surgery planning. All patients were ﬁnally reviewed during the
postoperative oncology meeting and chemotherapy was  proposed
according to the ﬁnal disease stage.
The accuracy in resectability evaluation after chemotherapy was
100% and all our patients underwent curative R0 resections. Fibrosis
was found after treatment and no vessels inﬁltration was revealed
by histopathology, even in the cases where there wasn’t an evident
clear plan on imaging between the main peripancreatic vessels and
the tumor (Fig. 16).
4. Discussion
The axial slicing technique is a dissection technique introduced
by C. Verbeke and is based on serial specimen slicing in the axial
plane [12], instead of the traditional procedure with longitudinal
opening of the main pancreatic and/or common bile duct and slic-
ing along the plane deﬁned by both ducts. Serial slicing along a
single ﬁxed plane (identical to the axial plane of computed tomog-
raphy) without disruption of the tumor and native structures allows
careful evaluation of the cancer and its relationship to both the var-
ious specimen surfaces and the key anatomical structures like the
surrounding vessels, as well as the entire circumferential margin
(CRM) [13]. These advantages are of great importance for accurate
staging and reliable identiﬁcation of tumor origin.
Axial slicing is easy to perform, regardless of the location and
nature of the pathology encountered, allowing extensive views
of the lesion as the entire surface (or CRM) of the pancreatic
head remains intact. The numerous specimen slices generated by
the axial dissection technique provide also excellent views of the
local anatomy and pathological changes. The application of this
technique furthermore enhances the ability of accurate radiologic-
pathologic correlation as the orientation of slices is similar with
axial CT and/or MRI.
Contrast enhanced images seem to better correlate with macro-
scopic ﬁndings as detailed evaluation of the structure and tumor
consistency is possible [14–18]. Concerning the cystic pancreatic
tumors, T2 w images correlated better with histopathology in all
tumor types. It should be noticed that in the microcystic adeno-
mas  contrast enhanced images were misleading, mainly because
of intense enhancement and the pseudo-solid appearance which
58 C. Triantopoulou et al. / European Journal of Radiology Open 3 (2016) 49–59
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lig. 16. A borderline resectable tumor on contrast enhanced CT before and after 
reatment changes adjacent to superior mesenteric artery (blue arrows in b). (For i
eb  version of this article.)
hould be kept in mind for this type of sponge-like tumors [19]. MRI
as also able to depict hemorrhagic content in SPT. On the other
and, differential diagnosis between inﬁltrative IPMN of the main
uct and pancreatic adenocarcinoma was not possible by imaging
n our cases. The size of the dilated pancreatic duct seems not to
orrelate directly with the possibility of the presence of an IPMN,
lthough it has been described in the literature as a worrisome
eature [20].
DWI  technique was not applied in all cases, but on the other
and the evaluation of this sequence was beyond the scope of this
rticle. Nevertheless, tt should be noted that even with the use
f this technique it was not possible to evaluate early develop-
ent of adenocarcinoma in the walls of a mucinous cyst in one
ase, while there was strong restriction in diffusion in a case of a
PT mimicking pancreatic adenocarcinoma. The well known over-
ap in ADC values of pancreatic cancer and mass-forming focalent (a). The radiologic-pathologic correlation of the specimen with evident post
etation of the references to color in this ﬁgure legend, the reader is referred to the
pancreatitis [21,22] was  also noticed in our study in the three
cases of wrong interpretation of sclerosing cholangitis with ﬁbrosis,
ampulla hyperplasia with ﬁbrosis and focal autoimmune pancre-
atitis as cholangiocarcinoma, periampullary tumor and pancreatic
adenocarcinoma respectively.
As far as accuracy in resectability status is concerned, it is known
that MDCT and MDCTA are the most effective tools used for the
therapeutic planning speciﬁcally in locally advanced and borderline
marginally resectable tumors [4]. This new category recognized as
“borderline resectable tumors” has lead to conﬂicting statements
on the accurate deﬁnition [23,24]. It seems that these patients
are not good candidates for immediate surgery, while the use of
preoperative chemotherapy may  increase the possibility of an R0
resection [25,26].
While histological diagnosis is not required for patients with
presumed pancreatic cancer who  are going to be treated with
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ﬁne needle aspiration of 545 focal pancreatic lesions, AJR 193 (2009)
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[28] M.H. Katz, J.B. Fleming, P. Bhosale, et al., Response of borderline resectable
pancreatic cancer to neoadjuvant therapy is not reﬂected by radiographicC. Triantopoulou et al. / European Jo
urgery, biopsy is required prior to initiation of neoadjuvant ther-
py in patients with borderline resectable pancreatic cancer. Fine
eedle aspiration (FNA) is the preferred method for obtaining a tis-
ue diagnosis and it is also applied in our center in patients with
orderline or unresectable pancreatic tumors. Percutaneous CT or
US guided FNA can be used alternatively, depending on the site
nd the size of the tumor [27].
In all but three cases in our study, preoperative imaging evalu-
tion was correct and R0 resections were achieved. In three cases
he tumor was ﬁnally more extended than predicted ending up to
1 resections. This was  mainly attributed to underestimation of
he degree of vessels inﬁltration, something also described in other
tudies. What is important to emphasize it that although in the lit-
rature the accuracy of MDCT and MDCTA vary according to the
ype of the scanner used, all authors agree that sensitivity and pos-
tive predictive value reach 100% while negative predictive value
nd speciﬁcity are lower (75–85% in different series).
Until now accurate speciﬁc criteria for the estimation of
esectability following chemotherapy are lacking, thus the evalua-
ion has to be done using the established resectability guidelines
efore treatment. Nevertheless it should be noted that ﬁbrosis
s a result of the treatment could be misinterpreted as residual
umor adjacent to the vessels. So, accurate evaluation speciﬁcally in
brotic tumors is not always possible and may  lead to overestima-
ion of tumors extent, preventing a possible curative operation. In
 recent study it is suggested that response of borderline resectable
ancreatic cancer to neoadjuvant therapy is not deﬁnitely reﬂected
y radiographic indicators [28] thus in the absence of metastases,
atients with borderline tumors may  undergo a surgical attempt
ven if they do not fully fulﬁll the criteria of resectability as esti-
ated by imaging.
. Conclusions
Radiologic-pathologic correlation of pancreatic tumors with the
xial slicing technique offers many advantages by adding important
nformation. First of all it permits a detailed quality assessment of
he surgical specimen and in the same time a retrospective eval-
ation of the possible missed additional ﬁndings or mismatches
etween imaging and histopathology ﬁndings. Through the recog-
ition of the histopathology basis of atypical ﬁndings, a better
nderstanding of the facts leading to incorrect radiologic interpre-
ation is achieved while in the same time the reasons of under-or
verstaging are more clearly depicted. This may  also serve as an
xcellent educational tool enhancing radiologists’ ability toward
ore accurate diagnoses and surgeons toward a better understand-
ng of imaging limitations.
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